Brief report: Long-term functional engraftment of mesenchymal progenitor cells in a mouse model of accelerated aging

Stem Cells

Volumn 31, Issue 3, 2013, Pages 607-611

  Singh, Lakshman ^a   Brennan, Tracy A ^a   Kim, Jung Hoon ^a   Egan, Kevin P ^a   McMillan, Emily A ^a   Chen, Qijun ^a   Hankenson, Kurt D ^a,b   Zhang, Yi ^c   Emerson, Stephen G ^d   Johnson, F Brad ^a   Pignolo, Robert J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Department of Medicine   (United States)

Author keywords

Aging; Engraftment; Mesenchymal stem cells; Osteoporosis; Telomere; Telomere dysfunction

Indexed keywords

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOLYSIS; WILD TYPE; ANIMAL; CELL AGING; CYTOLOGY; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; OSTEOPOROSIS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SURVIVAL; TELOMERE; TRANSGENIC MOUSE; METHODOLOGY;

AGING; ANIMALS; CELL AGING; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, TRANSGENIC; OSTEOPOROSIS; SURVIVAL ANALYSIS; TELOMERE;

EID: 84874834301     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1294     Document Type: Article

References (27)

1. Marie PJ, Kassem M. Extrinsic mechanisms involved in agerelated defective bone formation. J Clin Endocrinol Metab 2011;96: 600-609.
2. Kassem M, Marie PJ. Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. Aging Cell 2011;10: 191-197.
3. Mason PJ, Wilson DB, Bessler M. Dyskeratosis congenita - A disease of dysfunctional telomere maintenance. Curr Mol Med 2005;5: 159-170.
4. Hofer AC, Tran RT, Aziz OZ et al. Shared phenotypes among segmental progeroid syndromes suggest underlying pathways of aging. J Gerontol A Biol Sci Med Sci 2005;60: 10-20.
5. Du X, Shen J, Kugan N et al. Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol Cell Biol 2004;24: 8437-8446.
6. Lombard DB, Beard C, Johnson B et al. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 2000;20: 3286-3291.
7. Chang S, Multani AS, Cabrera NG et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 2004; 36: 877-882.
8. Pignolo RJ, Suda RK, McMillan EA et al. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell 2008;7: 23-31.
9. Wang H, Chen Q, Lee SH et al. Impairment of osteoblast differentiation due to proliferation-independent telomere dysfunction in mouse models of accelerated aging. Aging Cell 2012;11: 704-713.
10. Wong KK, Chang S, Weiler SR et al. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet 2000;26: 85-88.
11. Bernardo ME, Zaffaroni N, Novara F et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67: 9142-9149.
12. Simonsen JL, Rosada C, Serakinci N et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002;20: 592-596.
13. Yudoh K, Matsuno H, Nakazawa F et al. Reconstituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts. J Bone Miner Res 2001;16: 1453-1464.
14. Dominici M, Pritchard C, Garlits JE et al. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci USA 2004;101: 11761-11766.
15. Olmsted-Davis EA, Gugala Z, Camargo F et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci USA 2003;100: 15877-15882.
16. Bonyadi M, Waldman SD, Liu D et al. Mesenchymal progenitor selfrenewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly- 6A null mice. Proc Natl Acad Sci USA 2003;100: 5840-5845.
17. Kasper G, Mao L, Geissler S et al. Insights into mesenchymal stem cell aging: Involvement of antioxidant defense and actin cytoskeleton. Stem Cells 2009;27: 1288-1297.
18. Lavasani M, Robinson AR, Lu A et al. Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nat Commun 2012;3: 608.
19. Lee WY, Cho SW, Oh ES et al. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 2002;87: 329-335.
20. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5: 309-313.
21. Jones OY, Good RA, Cahill RA. Nonmyeloablative allogeneic bone marrow transplantation for treatment of childhood overlap syndrome and small vessel vasculitis. Bone Marrow Transplant 2004;33: 1061-1063.
22. Meuleman N, Vanhaelen G, Tondreau T et al. Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: A case report. Haematologica 2008;93:e11-13.
23. Pereira RF, O'Hara MD, Laptev AV et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 1998;95: 1142-1147.
24. Pozzi S, Lisini D, Podesta M et al. Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation. Exp Hematol 2006;34: 934-942.
25. Reyes M, Li S, Foraker J et al. Donor origin of multipotent adult progenitor cells in radiation chimeras. Blood 2005;106: 3646-3649.
26. Villaron EM, Almeida J, Lopez-Holgado N et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 2004;89: 1421-1427.
27. Ghavamzadeh A, Alimoghadam K, Nasseri P et al. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. Bone Marrow Transplant 1999;23: 299-301.